What is acute myeloid leukemia (AML)?
Produced in collaboration with The Leukemia & Lymphoma Society.
Support for this patient education program was provided by Pfizer Inc.
Acute myeloid leukemia (AML) is a rare and aggressive form of blood and bone marrow cancer that progresses rapidly without treatment. Trustworthy education is one of the most important and empowering tools for patients and caregivers, whether they're facing a new diagnosis or have already begun the battle.
If you or someone you care for has AML, join our interactive education program originally recorded live on July 24, 2017 with a panel of AML experts.
The four-part program covers:
• What is acute myeloid leukemia (AML)?
• How do test results help me and my doctors? • What are my options for treatment? • Where do I go for self-care information and support?
Patient Education on Acute Myeloid Leukemia:
Chapters and Extras
How do test results help me and my doctors?
What are my options for treatment?
Where do I go for self-care information and support?
Hundreds of questions came in before and during the live program. Watch this extra footage of the panel answering some they didn't get to during the live broadcast.